Pharmacogenetics Meets Metabolomics: Discovery of Tryptophan as a New Endogenous OCT2 Substrate Related to Metformin Disposition

PLoS ONE - United States
doi 10.1371/journal.pone.0036637
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Functional Metabolomics: From Biomarker Discovery to Metabolome Reprogramming

Protein & Cell
BiochemistryBiotechnologyDrug DiscoveryCell BiologyMedicine
2015English

Big Data, Big Picture: Metabolomics Meets Systems Biology

Science
MultidisciplinaryPhilosophy of ScienceHistory
2017English

Development of a GC/Quadrupole-Orbitrap Mass Spectrometer, Part II: New Approaches for Discovery Metabolomics

Analytical Chemistry
Analytical Chemistry
2014English

The Pharmacogenetics Research Network: From SNP Discovery to Clinical Drug Response

Clinical Pharmacology and Therapeutics
Pharmacology
2007English

A Region Corresponding to Second Aspartate-Rich Motif in Tryptophan Isoprenylating Enzyme, ComQ, Serves as a Substrate-Binding Site

Bioscience, Biotechnology and Biochemistry
Organic ChemistryApplied MicrobiologyMolecular BiologyBiochemistryAnalytical ChemistryMedicineBiotechnology
2014English

Microfluidics Meets Metabolomics to Reveal the Impact of Campylobacter Jejuni Infection on Biochemical Pathways

Biomedical Microdevices
NanotechnologyBiomedical EngineeringMolecular BiologyNanoscience
2016English

Metabolomics-Based Discovery of a Metabolite That Enhances Oligodendrocyte Maturation

Nature Chemical Biology
Cell BiologyMolecular Biology
2017English

ABCG2 Pharmacogenetics: Ethnic Differences in Allele Frequency and Assessment of Influence on Irinotecan Disposition

Clinical Cancer Research
Cancer ResearchOncology
2004English

Fragment-Based Ligand Discovery Meets Phage Display

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy